. Ehpad-de-saint-julien, RDC et 1 er étage), la part d'utilisation de la forme orale est en moyenne de 63% (±4%), pour les unités du service des maladies infectieuses et tropicales (Unités 90 et 91) elle est de 64% (±13%) et pour l'unité régionale de soins palliatifs de 35% (±14%)

F. Jibril, S. Sharaby, M. A. Wilby, and K. , Intravenous versus Oral Acetaminophen for Pain: Systematic Review of Current Evidence to Support Clinical Decision-Making, The Canadian Journal of Hospital Pharmacy, vol.68, issue.3, pp.238-285, 2015.
DOI : 10.4212/cjhp.v68i3.1458

R. Ghiculescu, P. Kubler, and P. Gleeson, Drug utilization evaluation of i.v. paracetamol at a large teaching hospital, Internal Medicine Journal, vol.10, issue.9, pp.620-623, 2007.
DOI : 10.1046/j.1365-2125.2003.02029.x

C. Paillé-ricolleau, C. Lejus, G. Potel, P. Lombrail, and L. Moret, Pertinence des prescriptions de parac??tamol IV au CHU de Nantes??: un indicateur de suivi pour l???am??lioration des pratiques, La Presse M??dicale, vol.39, issue.4, pp.511-513, 2010.
DOI : 10.1016/j.lpm.2009.11.012

A. Cahn and P. Hepp, Sur l'action de l'antifébrine (acétanilide) et de quelques corps analogues, Prog Méd J Médecine Chir Pharm, vol.5, pp.43-49, 1887.

B. Lebrun-vignes, Enqu??tes de pharmacovigilance des ann??es 2000??et allergies cutan??es m??dicamenteuses, Revue Fran??aise d'Allergologie, vol.52, issue.3, pp.223-229, 2012.
DOI : 10.1016/j.reval.2012.01.013

J. Vane, Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs, Nature New Biology, vol.231, issue.25, pp.232-237, 1971.
DOI : 10.1038/newbio231232a0

C. Sharma and V. Mehta, Paracetamol: mechanisms and updates. Contin Educ Anaesth Crit Care Pain, pp.153-161, 2014.
DOI : 10.1093/bjaceaccp/mkt049

R. Flower and J. Vane, Inhibition of Prostaglandin Synthetase in Brain explains the Anti-pyretic Activity of Paracetamol (4-Acetamidophenol), Nature, vol.7, issue.5381, pp.410-411, 1972.
DOI : 10.1038/240410a0

A. Hanel and W. Lands, Modification of anti-inflammatory drug effectiveness by ambient lipid peroxides, Biochemical Pharmacology, vol.31, issue.20, pp.3307-3318, 1982.
DOI : 10.1016/0006-2952(82)90565-2

D. Aronoff, J. Oates, and O. Boutaud, New insights into the mechanism of action of acetaminophen: Its clinical pharmacologic characteristics reflect its inhibition of the two prostaglandin H2 synthases, Clinical Pharmacology & Therapeutics, vol.79, issue.1, pp.9-19, 2006.
DOI : 10.1016/j.clpt.2005.09.009

R. Lucas, Cellular mechanisms of acetaminophen: role of cyclo-oxygenase, FASEB J [Internet]. 24 janv 2005 Disponible sur, 2016.
DOI : 10.1096/fj.04-2437fje

N. Chandrasekharan, H. Dai, K. Roos, N. Evanson, J. Tomsik et al., COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression, Proceedings of the National Academy of Sciences, vol.96, issue.6, pp.13926-13957, 2002.
DOI : 10.1073/pnas.96.6.3275

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC129799

B. Kis, J. Snipes, and D. Busija, Acetaminophen and the Cyclooxygenase-3 Puzzle: Sorting out Facts, Fictions, and Uncertainties, Journal of Pharmacology and Experimental Therapeutics, vol.315, issue.1, pp.1-7, 2005.
DOI : 10.1124/jpet.105.085431

A. Tjølsen, A. Lund, and K. Hole, Antinociceptive effect of paracetamol in rats is partly dependent on spinal serotonergic systems, European Journal of Pharmacology, vol.193, issue.2, pp.193-201, 1991.
DOI : 10.1016/0014-2999(91)90036-P

C. Mallet, L. Daulhac, J. Bonnefont, C. Ledent, E. M. Chapuy et al., Endocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia, Pain, vol.139, issue.1, pp.190-200, 2008.
DOI : 10.1016/j.pain.2008.03.030

J. Bonnefont, A. Alloui, E. Chapuy, E. Clottes, and A. Eschalier, Orally Administered Paracetamol Does Not Act Locally in the Rat Formalin Test, Anesthesiology, vol.99, issue.4, pp.976-81, 2003.
DOI : 10.1097/00000542-200310000-00034

G. Pickering, V. Estève, M. Loriot, A. Eschalier, and C. Dubray, Acetaminophen Reinforces Descending Inhibitory Pain Pathways, Clinical Pharmacology & Therapeutics, vol.6, issue.1, pp.47-51, 2008.
DOI : 10.1038/sj.clpt.6100403

A. Bertolini, A. Ferrari, A. Ottani, S. Guerzoni, R. Tacchi et al., Paracetamol: New Vistas of an Old Drug, CNS Drug Reviews, vol.316, issue.2, pp.250-75, 2006.
DOI : 10.1016/S0014-2999(00)00207-7

A. Hohmann and R. Suplita, Endocannabinoid mechanisms of pain modulation, The AAPS Journal, vol.8, issue.4, pp.693-708, 2006.
DOI : 10.1208/aapsj080479

E. Hogestatt, B. Jonsson, A. Ermund, D. Andersson, H. Bjork et al., Conversion of Acetaminophen to the Bioactive N-Acylphenolamine AM404 via Fatty Acid Amide Hydrolase-dependent Arachidonic Acid Conjugation in the Nervous System, Journal of Biological Chemistry, vol.280, issue.36, pp.31405-31417, 2005.
DOI : 10.1074/jbc.M501489200

A. Ottani, S. Leone, M. Sandrini, A. Ferrari, and A. Bertolini, The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors, European Journal of Pharmacology, vol.531, issue.1-3, pp.280-281, 2006.
DOI : 10.1016/j.ejphar.2005.12.015

D. Cichewicz, Synergistic interactions between cannabinoid and opioid analgesics, Life Sciences, vol.74, issue.11, pp.1317-1341, 2004.
DOI : 10.1016/j.lfs.2003.09.038

M. Bujalska, Effect of nitric oxide synthase inhibition on antinociceptive action of different doses of acetaminophen, Pol J Pharmacol. oct, vol.56, issue.5, pp.605-615, 2004.

H. Smith, Potential analgesic mechanisms of acetaminophen, Pain Physician. févr, vol.12, issue.1, pp.269-80, 2009.

F. Baud, P. Hantson, and H. Thabet, Intoxications aiguës, 2013.
DOI : 10.1007/978-2-8178-0301-2

P. Ging, O. Mikulich, O. Reilly, and K. , Unexpected paracetamol (acetaminophen) hepatotoxicity at standard dosage in two older patients: time to rethink 1 g four times daily?: Table 1., Age and Ageing, vol.45, issue.4, pp.566-573, 2016.
DOI : 10.1093/ageing/afw067

S. Seifert, D. Kovnat, V. Anderson, J. Green, R. Dart et al., Acute hepatotoxicity associated with therapeutic doses of intravenous acetaminophen, Clinical Toxicology, vol.40, issue.3, 2016.
DOI : 10.1007/s13181-015-0476-x

J. Stollings, A. Wheeler, and T. Rice, Incidence and characterization of acute kidney injury after acetaminophen overdose, Journal of Critical Care, vol.35, pp.191-195, 2016.
DOI : 10.1016/j.jcrc.2016.06.004

P. Blakely and B. Mcdonald, Acute renal failure due to acetaminophen ingestion: a case report and review of the literature, J Am Soc Nephrol JASN. juill, vol.6, issue.1, pp.48-53, 1995.

L. Schmidt and K. Dalhoff, Hyperamylasaemia and acute pancreatitis in paracetamol poisoning, Alimentary Pharmacology and Therapeutics, vol.42, issue.2, pp.173-182, 2004.
DOI : 10.1097/00006676-200003000-00009

M. Boyle, L. Nicholson, O. Brien, M. Flynn, G. Collins et al., Paracetamol induced skin blood flow and blood pressure changes in febrile intensive care patients: An observational study, Australian Critical Care, vol.23, issue.4, pp.208-222, 2010.
DOI : 10.1016/j.aucc.2010.06.004

A. Kraj?ová, V. Matou?ek, and F. Du?ka, Mechanism of paracetamol-induced hypotension in critically ill patients: A prospective observational cross-over study, Australian Critical Care, vol.26, issue.3, pp.136-177, 2013.
DOI : 10.1016/j.aucc.2012.02.002

J. Forman, E. Rimm, and G. Curhan, Frequency of Analgesic Use and Risk of Hypertension Among Men, Archives of Internal Medicine, vol.167, issue.4, pp.394-403, 2007.
DOI : 10.1001/archinte.167.4.394

J. Forman, M. Stampfer, and G. Curhan, Non-Narcotic Analgesic Dose and Risk of Incident Hypertension in US Women, Hypertension, vol.46, issue.3, pp.500-507, 2005.
DOI : 10.1161/01.HYP.0000177437.07240.70

B. Montgomery, Does paracetamol cause hypertension?, BMJ, vol.336, issue.7654, pp.1190-1191, 2008.
DOI : 10.1136/bmj.39526.654016.AD

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394642

A. Ubeda, J. Llopico, and M. Sanchez, Blood pressure reduction in hypertensive patients after withdrawal of effervescent medication, Pharmacoepidemiology and Drug Safety, vol.9, issue.5, pp.417-426, 2009.
DOI : 10.1002/pds.1701

M. Magnus, Ø. Karlstad, S. Håberg, P. Nafstad, D. Smith et al., Prenatal and infant paracetamol exposure and development of asthma: the Norwegian Mother and Child Cohort Study, International Journal of Epidemiology, vol.45, issue.2, 2016.
DOI : 10.1093/ije/dyv366

I. Eneli, K. Sadri, C. Jr, C. , G. Barr et al., Acetaminophen and the Risk of Asthma, Chest, vol.127, issue.2, pp.604-616, 2005.
DOI : 10.1378/chest.127.2.604

T. Mckeever, S. Lewis, H. Smit, P. Burney, J. Britton et al., The Association of Acetaminophen, Aspirin, and Ibuprofen with Respiratory Disease and Lung Function, American Journal of Respiratory and Critical Care Medicine, vol.171, issue.9, pp.966-71, 2005.
DOI : 10.1164/rccm.200409-1269OC

G. Gould, A. Seillier, G. Weiss, A. Giuffrida, T. Burke et al., Acetaminophen differentially enhances social behavior and cortical cannabinoid levels in inbred mice, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.38, issue.2, pp.260-269, 2012.
DOI : 10.1016/j.pnpbp.2012.04.011

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389197

K. Blecharz-klin, A. Piechal, J. Pyrzanowska, I. Joniec-maciejak, P. Kiliszek et al., Paracetamol???The outcome on neurotransmission and spatial learning in rats, Behavioural Brain Research, vol.253, pp.157-64, 2013.
DOI : 10.1016/j.bbr.2013.07.008

A. Ruha and B. Seldem, Hemolytic anemia after acetaminophen overdose in a patient with glucose-6-phosphate dehydrogenase deficiency, The American Journal of Medicine, vol.110, issue.3, pp.240-241, 2001.
DOI : 10.1016/S0002-9343(00)00723-3

R. Walter, F. Milano, T. Brasky, and E. White, Long-Term Use of Acetaminophen, Aspirin, and Other Nonsteroidal Anti-Inflammatory Drugs and Risk of Hematologic Malignancies: Results From the Prospective Vitamins and Lifestyle (VITAL) Study, Journal of Clinical Oncology, vol.29, issue.17, pp.2424-2455, 2011.
DOI : 10.1200/JCO.2011.34.6346

R. Walter, T. Brasky, and E. White, Cancer Risk Associated with Long-term Use of Acetaminophen in the Prospective VITamins and Lifestyle (VITAL) Study, Cancer Epidemiology Biomarkers & Prevention, vol.20, issue.12, pp.2637-2678, 2011.
DOI : 10.1158/1055-9965.EPI-11-0709

L. Baandrup, S. Friis, C. Dehlendorff, K. Andersen, J. Olsen et al., Prescription Use of Paracetamol and Risk for Ovarian Cancer in Denmark, JNCI: Journal of the National Cancer Institute, vol.106, issue.6, p.111, 2014.
DOI : 10.1093/jnci/dju111

E. Jacobs, C. Newton, V. Stevens, and S. Gapstur, A Large Cohort Study of Long-term Acetaminophen Use and Prostate Cancer Incidence, Cancer Epidemiology Biomarkers & Prevention, vol.20, issue.7, pp.1322-1330, 2011.
DOI : 10.1158/1055-9965.EPI-11-0210

L. Van-diem and J. Grilliat, Anaphylactic shock induced by paracetamol, European Journal of Clinical Pharmacology, vol.1, issue.4, pp.389-90, 1990.
DOI : 10.1007/BF00315581

J. Guccione, A. Zemtsov, E. Cobos, and K. Neldner, Acquired purpura fulminans induced by alcohol and acetaminophen. Successful treatment with heparin and vitamin K, Archives of Dermatology, vol.129, issue.10, pp.1267-1276, 1993.
DOI : 10.1001/archderm.129.10.1267

V. Boccaletti, C. Cortelazzi, C. Fantini, E. Tognetti, G. Fabrizi et al., Acute generalized exanthematous pustulosis following paracetamol ingestion in a child, Pediatric Allergy and Immunology, vol.37, issue.4, pp.391-393, 2015.
DOI : 10.1111/pai.12386

S. Biswal and S. Sahoo, Paracetamol induced Stevens-Johnson syndrome - toxic epidermal necrolysis overlap syndrome, International Journal of Dermatology, vol.182, issue.8, pp.1042-1046, 2014.
DOI : 10.1111/ijd.12355

E. Walter, Actualités en néonatalogie : de la littérature à la pratique quotidienne

. Loi, relative à l'assurance maladie, 2004.

H. Autorité and D. Santé, L'évaluation des pratiques professionnelles dans le cadre de l'accrédidation des établissements de santé [Internet], 2005.

H. Autorité and D. Santé, EPP : mode d'emploi [Internet], 2007.

H. Autorité-de-santé, Disponible sur: http://www.has-sante.fr/portail, pp.20142013-20142015, 2016.

H. Autorité and D. Santé, Audit clinique : Evaluation des pratiques par comparaison à un référentiel [Internet] Disponible sur: www.hassante.fr/portail/upload/docs, 2004.

J. Grimshaw and I. Russell, Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations, The Lancet, vol.342, issue.8883, pp.1317-1339, 1993.
DOI : 10.1016/0140-6736(93)92244-N

A. Oxman, M. Thomson, D. Davis, and R. Haynes, No magic bullets: a systematic review of 102 trials of interventions to improve professional practice, CMAJ Can Med Assoc J J Assoc Medicale Can. 15 nov, vol.153, issue.10, pp.1423-1454, 1995.

H. Chin and P. Wallace, Embedding guidelines into direct physician order entry: simple methods, powerful results, Proc AMIA Annu Symp AMIA Symp, 1999.

S. Eslami, A. Abu-hanna, and N. De-keizer, Evaluation of Outpatient Computerized Physician Medication Order Entry Systems: A Systematic Review, Journal of the American Medical Informatics Association, vol.14, issue.4, pp.400-406, 2007.
DOI : 10.1197/jamia.M2238

L. Duff and M. , Paracétamol : privilégier la voie orale [Internet] Conférence régionale des pharmaciens des établissements de santé de Bretagne Disponible sur: cr-ph-eds-bzh, 2006.

C. Duez, Bon usage du paracétamol injectable à l'Hôpital Tenon [Thèse d'exercice], Faculté des sciences pharmaceutiques et biologiques, 2006.

C. Ballandras, J. Rocquain, I. Pons, C. Delom, P. Noceto et al., Efficience des prescriptions de paracétamol injectable : L'infirmier a son rôle à jouer ! Hopipharm, p.2015, 2015.

C. Hôpitaux-de-rouen, Chiffres clés -Activité 2014, p.2014, 2016.

K. Champion, S. Mouly, C. Lloret-linares, A. Lopes, E. Vicaut et al., Optimizing the Use of Intravenous Therapy in Internal Medicine, The American Journal of Medicine, vol.126, issue.10, pp.925-926, 2013.
DOI : 10.1016/j.amjmed.2013.03.028

J. Rwabihama, R. Aubourg, J. Oliary, S. Mouly, K. Champion et al., Usage et m??susage de la voie intraveineuse pour l???administration de m??dicaments en m??decine interne, La Presse M??dicale, vol.35, issue.10, pp.1453-60, 2006.
DOI : 10.1016/S0755-4982(06)74834-5

I. Marie, A. Moutot, A. Tharrasse, M. Hellot, S. Robaday et al., Ad??quation aux??recommandations des??prescriptions des??inhibiteurs de??la??pompe ????protons dans??un??service de??m??decine interne, La Revue de M??decine Interne, vol.28, issue.2, pp.86-93, 2007.
DOI : 10.1016/j.revmed.2006.09.030

H. Autorité and D. Santé, Bon usage du médicament -Les inhibiteurs de la pompe à protons chez l'adulte [Internet] Disponible sur: www.has-sante, pp.2009-2015, 2009.

L. Roulet, N. Vernaz, E. Giostra, Y. Gasche, and J. Desmeules, Effets indésirables des inhibiteurs de la pompe à proton : faut-il craindre de les prescrire au long cours ? Rev Médecine Interne, août, vol.33, issue.8, pp.439-484, 2012.
DOI : 10.1016/j.revmed.2011.12.011

C. Bourne, B. Charpiat, N. Charhon, C. Bertin, A. Gouraud et al., Effets ind??sirables ??mergents des inhibiteurs de la pompe ?? protons, La Presse M??dicale, vol.42, issue.2, pp.53-62, 2013.
DOI : 10.1016/j.lpm.2012.09.016